Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q2 FY26
Bearish
4
Neutral
5
Bullish
5
Bearish
36
Neutral
5
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
5
Bullish
5
Bearish
4
Neutral
5
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Pharmaceuticals & Biotechnology
Pharmaceuticals
244 Cr
Low Risk
20.8
34.8
2.2
3.2
610.00
340.15
Sales CAGR
Profit CAGR
ROE
ROCE
BDH Industries Ltd (BDH) is currently trading at 425.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
BDH Industries Limited is a Mumbai‑based manufacturer of pharmaceutical formulations (primarily oral solid dosages) with a small renewable energy arm operating wind turbines; the company maintains an R&D centre at Kandivali focused on formulation development and novel drug delivery systems, and reports consolidated standalone financials showing operations in Pharmaceuticals and Renewable Energy. Q1 FY2026‑27 results show total standalone income of ₹2,282.41 lakhs and revenue from operations of ₹2,237.91 lakhs, up materially year‑on‑year versus Q1 FY2025; Profit after Tax for the quarter was ₹272.30 lakhs, representing strong sequential and annual improvement and indicating resilient profitability at its current scale. The financials show concentrated revenue exposure to Pharmaceuticals, which contributed ~98% of Q1 revenues (₹2,203.16 lakhs), while Renewable Energy contributed a small but improved segment profit of ₹22.30 lakhs; the company reports low finance costs and a modest effective tax rate, implying limited leverage and steady net margin generation for a mid‑sized manufacturer. Operational strengths include an in‑house R&D capability focused on NDDS and OSD technologies, historical experience since 1990 and selective international collaboration (an MoU for assistance in Nepal), while risks include high revenue concentration in pharmaceuticals, limited scale in renewables and exposure to pricing and regulatory pressure in generics markets.
Over the past 52 weeks, BDH Industries Ltd has traded between a low of ₹340.15 and a high of ₹610.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
BDH Industries Ltd has a market capitalization of approximately 244.02. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
BDH Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.84 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 244.02 Cr, BDH Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
BDH Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of BDH Industries Ltd is 20.84. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
BDH Industries reported net profit of ₹2.72 crore for the quarter ended June 2026, up from ₹1.83 crore in the quarter ended June 2025.
